{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:28:47Z","timestamp":1785032927634,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10552-023-01838-0","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T07:02:46Z","timestamp":1704351766000},"page":"771-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphedema self-assessment among endometrial cancer survivors"],"prefix":"10.1007","volume":"35","author":[{"given":"Jordyn A.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Bae-Jump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeyemi A.","family":"Ogunleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephenie","family":"Black-Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel B.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"1838_CR2","unstructured":"National Cancer Institute. Cancer Stat Facts: Uterine Cancer. [Internet]. Accessed June 16 (2023) Accessed at: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html"},{"key":"1838_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","volume":"8","author":"MA Clarke","year":"2022","unstructured":"Clarke MA, Devesa SS, Hammer A, Wentzensen N (2022) Racial and ethnic differences in hysterectomy-corrected uterine Corpus Cancer Mortality by Stage and histologic subtype. JAMA Oncol 8:895\u2013903. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0009","journal-title":"JAMA Oncol"},{"key":"1838_CR4","doi-asserted-by":"publisher","first-page":"100922","DOI":"10.1016\/j.gore.2022.100922","volume":"40","author":"DH Saris","year":"2022","unstructured":"Saris DH, Smith AJB, Brensinger C et al (2022) Disparities in cancer-specific and overall survival in black women with endometrial cancer: a Medicare-SEER study. Gynecologic Oncol Rep 40:100922. https:\/\/doi.org\/10.1016\/j.gore.2022.100922","journal-title":"Gynecologic Oncol Rep"},{"key":"1838_CR5","unstructured":"National Cancer Institute Surveillance Epidemiology and End Results Program SEER*Explorer: An interactive website for SEER cancer statistics. [Internet]. Accessed August 1 (2023) Accessed at: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/"},{"key":"1838_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ijc.32740","volume":"147","author":"AS Felix","year":"2020","unstructured":"Felix AS, McLaughlin EM, Caan BJ, Cohn DE, Anderson GL, Paskett ED (2020) Guideline-concordant endometrial cancer treatment and survival in the women\u2019s Health Initiative Life and Longevity after Cancer study. Int J Cancer 147:404\u2013412. https:\/\/doi.org\/10.1002\/ijc.32740","journal-title":"Int J Cancer"},{"key":"1838_CR7","doi-asserted-by":"publisher","first-page":"398e1","DOI":"10.1016\/j.ajog.2020.02.041","volume":"223","author":"M Kaspers","year":"2020","unstructured":"Kaspers M, Llamocca E, Quick A, Dholakia J, Salani R, Felix AS (2020) Black and hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Am J Obstet Gynecol 223:398e1\u2013e18. https:\/\/doi.org\/10.1016\/j.ajog.2020.02.041","journal-title":"Am J Obstet Gynecol"},{"key":"1838_CR8","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/jco.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607\u20132618. https:\/\/doi.org\/10.1200\/jco.2012.48.2596","journal-title":"J Clin Oncol"},{"key":"1838_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ygyno.2013.02.023","volume":"129","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Felix AS, McMeekin DS et al (2013) Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 129:277\u2013284. https:\/\/doi.org\/10.1016\/j.ygyno.2013.02.023","journal-title":"Gynecol Oncol"},{"key":"1838_CR10","doi-asserted-by":"publisher","first-page":"e221671","DOI":"10.1001\/jamanetworkopen.2022.1671","volume":"5","author":"X Zhang","year":"2022","unstructured":"Zhang X, McLaughlin EM, Krok-Schoen JL et al (2022) Association of Lower Extremity Lymphedema with Physical Functioning and activities of Daily Living among older survivors of colorectal, endometrial, and Ovarian Cancer. JAMA Netw Open 5:e221671. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1671","journal-title":"JAMA Netw Open"},{"key":"1838_CR11","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00520-013-1879-3","volume":"21","author":"G Dunberger","year":"2013","unstructured":"Dunberger G, Lindquist H, Waldenstr\u00f6m AC, Nyberg T, Steineck G, \u00c5vall-Lundqvist E (2013) Lower limb lymphedema in gynecological cancer survivors\u2013effect on daily life functioning. Support Care Cancer 21:3063\u20133070. https:\/\/doi.org\/10.1007\/s00520-013-1879-3","journal-title":"Support Care Cancer"},{"key":"1838_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1525-1438.2006.00601.x","volume":"16","author":"K Bergmark","year":"2006","unstructured":"Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (2006) Lymphedema and bladder-emptying difficulties after radical hysterectomy for early Cervical cancer and among population controls. Int J Gynecol Cancer 16:1130\u20131139. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00601.x","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR13","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/cncr.22684","volume":"109","author":"V Beesley","year":"2007","unstructured":"Beesley V, Janda M, Eakin E, Obermair A, Battistutta D (2007) Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer 109:2607\u20132614. https:\/\/doi.org\/10.1002\/cncr.22684","journal-title":"Cancer"},{"key":"1838_CR14","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1002\/cncr.25458","volume":"116","author":"JN Cormier","year":"2010","unstructured":"Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond Breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116:5138\u20135149. https:\/\/doi.org\/10.1002\/cncr.25458","journal-title":"Cancer"},{"key":"1838_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s1053-4296(03)00038-9","volume":"13","author":"AL Cheville","year":"2003","unstructured":"Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME (2003) The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol 13:214\u2013225. https:\/\/doi.org\/10.1016\/s1053-4296(03)00038-9","journal-title":"Semin Radiat Oncol"},{"key":"1838_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ygyno.2010.06.018","volume":"119","author":"Y Todo","year":"2010","unstructured":"Todo Y, Yamamoto R, Minobe S et al (2010) Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 119:60\u201364. https:\/\/doi.org\/10.1016\/j.ygyno.2010.06.018","journal-title":"Gynecol Oncol"},{"key":"1838_CR17","first-page":"451","volume":"92","author":"T Manchana","year":"2009","unstructured":"Manchana T, Sirisabya N, Lertkhachonsuk R et al (2009) Long term Complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai 92:451\u2013456","journal-title":"J Med Assoc Thai"},{"key":"1838_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/bf03038982","volume":"174","author":"M Chatani","year":"1998","unstructured":"Chatani M, Nose T, Masaki N, Inoue T (1998) Adjuvant radiotherapy after radical hysterectomy of the Cervical cancer. Prognostic factors and Complications. Strahlenther Onkol 174:504\u2013509. https:\/\/doi.org\/10.1007\/bf03038982","journal-title":"Strahlenther Onkol"},{"key":"1838_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0090-8258(90)90374-t","volume":"37","author":"AP Soisson","year":"1990","unstructured":"Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT (1990) Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA Cervical cancer. Gynecol Oncol 37:390\u2013395. https:\/\/doi.org\/10.1016\/0090-8258(90)90374-t","journal-title":"Gynecol Oncol"},{"key":"1838_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00066-008-1728-3","volume":"184","author":"J F\u00fcller","year":"2008","unstructured":"F\u00fcller J, Guderian D, K\u00f6hler C, Schneider A, Wendt TG (2008) Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for Cervical cancer. Strahlenther Onkol 184:206\u2013211. https:\/\/doi.org\/10.1007\/s00066-008-1728-3","journal-title":"Strahlenther Onkol"},{"key":"1838_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1188\/03.Onf.417-423","volume":"30","author":"M Ryan","year":"2003","unstructured":"Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T (2003) The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum 30:417\u2013423. https:\/\/doi.org\/10.1188\/03.Onf.417-423","journal-title":"Oncol Nurs Forum"},{"key":"1838_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1586\/erp.11.30","volume":"11","author":"A Finnane","year":"2011","unstructured":"Finnane A, Hayes SC, Obermair A, Janda M (2011) Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcomes Res 11:287\u2013297. https:\/\/doi.org\/10.1586\/erp.11.30","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1838_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0738-081x(95)00086-u","volume":"13","author":"J Dar\u00f3czy","year":"1995","unstructured":"Dar\u00f3czy J (1995) Pathology of Lymphedema. Clin Dermatol 13:433\u2013444. https:\/\/doi.org\/10.1016\/0738-081x(95)00086-u","journal-title":"Clin Dermatol"},{"key":"1838_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/082585970602200102","volume":"22","author":"M Frid","year":"2006","unstructured":"Frid M, Strang P, Friedrichsen MJ, Johansson K (2006) Lower limb lymphedema: experiences and perceptions of cancer patients in the late palliative stage. J Palliat Care 22:5\u201311","journal-title":"J Palliat Care"},{"key":"1838_CR25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.apmr.2010.03.021","volume":"91","author":"E Katz","year":"2010","unstructured":"Katz E, Dugan NL, Cohn JC, Chu C, Smith RG, Schmitz KH (2010) Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study. Arch Phys Med Rehabil 91:1070\u20131076. https:\/\/doi.org\/10.1016\/j.apmr.2010.03.021","journal-title":"Arch Phys Med Rehabil"},{"key":"1838_CR26","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1097\/01.Ncc.0000281734.48479.33","volume":"30","author":"S Lockwood-Rayermann","year":"2007","unstructured":"Lockwood-Rayermann S (2007) Lymphedema in gynecologic cancer survivors: an area for exploration? Cancer Nurs 30:E11\u2013E18. https:\/\/doi.org\/10.1097\/01.Ncc.0000281734.48479.33","journal-title":"Cancer Nurs"},{"key":"1838_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.0004-8666.2003.00040.x","volume":"43","author":"M Ryan","year":"2003","unstructured":"Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P (2003) Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol 43:148\u2013151. https:\/\/doi.org\/10.1046\/j.0004-8666.2003.00040.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1838_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ygyno.2012.02.023","volume":"125","author":"FJ Backes","year":"2012","unstructured":"Backes FJ, Brudie LA, Farrell MR et al (2012) Short- and long-term morbidity and outcomes after robotic Surgery for comprehensive endometrial cancer staging. Gynecol Oncol 125:546\u2013551. https:\/\/doi.org\/10.1016\/j.ygyno.2012.02.023","journal-title":"Gynecol Oncol"},{"key":"1838_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1188\/07.Onf.937-940","volume":"34","author":"K Appollo","year":"2007","unstructured":"Appollo K (2007) Lower-extremity lymphedema in a patient with gynecologic cancer. Oncol Nurs Forum 34:937\u2013940. https:\/\/doi.org\/10.1188\/07.Onf.937-940","journal-title":"Oncol Nurs Forum"},{"key":"1838_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/pon.1249","volume":"17","author":"V Beesley","year":"2008","unstructured":"Beesley V, Eakin E, Steginga S, Aitken J, Dunn J, Battistutta D (2008) Unmet needs of gynaecological cancer survivors: implications for developing community support services. Psychooncology 17:392\u2013400. https:\/\/doi.org\/10.1002\/pon.1249","journal-title":"Psychooncology"},{"key":"1838_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.suronc.2020.09.005","volume":"35","author":"M Lopez","year":"2020","unstructured":"Lopez M, Roberson ML, Strassle PD, Ogunleye A (2020) Epidemiology of Lymphedema-related admissions in the United States: 2012\u20132017. Surg Oncol 35:249\u2013253. https:\/\/doi.org\/10.1016\/j.suronc.2020.09.005","journal-title":"Surg Oncol"},{"key":"1838_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamaoncol.2020.7891","volume":"7","author":"ML Roberson","year":"2021","unstructured":"Roberson ML, Strassle PD, Fasehun LO, Erim DO, Deune EG, Ogunleye AA (2021) Financial Burden of Lymphedema Hospitalizations in the United States. JAMA Oncol 7:630\u2013632. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7891","journal-title":"JAMA Oncol"},{"key":"1838_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2023.2017","author":"JV Lynn","year":"2023","unstructured":"Lynn JV, Hespe GE, Akhter MF, David CM, Kung TA, Myers PL (2023) Cross-sectional Analysis of Insurance Coverage for Lymphedema Treatments in the United States. JAMA Surg. https:\/\/doi.org\/10.1001\/jamasurg.2023.2017","journal-title":"JAMA Surg"},{"key":"1838_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003141.pub2","author":"C Badger","year":"2004","unstructured":"Badger C, Preston N, Seers K, Mortimer P (2004) Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev Cd003141. https:\/\/doi.org\/10.1002\/14651858.CD003141.pub2","journal-title":"Cochrane Database Syst Rev Cd003141"},{"key":"1838_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/ijgc-2019-001032","volume":"30","author":"K Dessources","year":"2020","unstructured":"Dessources K, Aviki E, Leitao MM Jr (2020) Lower extremity lymphedema in patients with gynecologic malignancies. Int J Gynecol Cancer 30:252\u2013260. https:\/\/doi.org\/10.1136\/ijgc-2019-001032","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR36","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/ijgc-2020-001532","volume":"30","author":"JMT Baiocchi","year":"2020","unstructured":"Baiocchi JMT, Baiocchi G, Bergmann A (2020) Is there a place for lower limb lymphedema prevention after Cervical cancer treatment? Int J Gynecol Cancer 30:1260. https:\/\/doi.org\/10.1136\/ijgc-2020-001532","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.avsg.2017.03.197","volume":"44","author":"Y Bakar","year":"2017","unstructured":"Bakar Y, Tu\u011fral A (2017) Lower extremity Lymphedema Management after Gynecologic Cancer Surgery: a review of current management strategies. Ann Vasc Surg 44:442\u2013450. https:\/\/doi.org\/10.1016\/j.avsg.2017.03.197","journal-title":"Ann Vasc Surg"},{"key":"1838_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ygyno.2019.10.009","volume":"156","author":"JW Carlson","year":"2020","unstructured":"Carlson JW, Kauderer J, Hutson A et al (2020) GOG 244-The lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients. Gynecol Oncol 156:467\u2013474. https:\/\/doi.org\/10.1016\/j.ygyno.2019.10.009","journal-title":"Gynecol Oncol"},{"key":"1838_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/IGC.0b013e3182466950","volume":"22","author":"JH Kim","year":"2012","unstructured":"Kim JH, Choi JH, Ki EY et al (2012) Incidence and risk factors of lower-extremity lymphedema after radical Surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA Cervical cancer. Int J Gynecol Cancer 22:686\u2013691. https:\/\/doi.org\/10.1097\/IGC.0b013e3182466950","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/IGC.0b013e3181da29d0","volume":"20","author":"MJ Halaska","year":"2010","unstructured":"Halaska MJ, Novackova M, Mala I et al (2010) A prospective study of postoperative lymphedema after Surgery for Cervical cancer. Int J Gynecol Cancer 20:900\u2013904. https:\/\/doi.org\/10.1111\/IGC.0b013e3181da29d0","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR41","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/igc.0000000000000226","volume":"24","author":"R Salani","year":"2014","unstructured":"Salani R, Preston MM, Hade EM et al (2014) Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing Surgery for endometrial cancer. Int J Gynecol Cancer 24:1507\u20131512. https:\/\/doi.org\/10.1097\/igc.0000000000000226","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/aog.0000000000000372","volume":"124","author":"KJ Yost","year":"2014","unstructured":"Yost KJ, Cheville AL, Al-Hilli MM et al (2014) Lymphedema after Surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol 124:307\u2013315. https:\/\/doi.org\/10.1097\/aog.0000000000000372","journal-title":"Obstet Gynecol"},{"key":"1838_CR43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ygyno.2006.03.055","volume":"103","author":"NR Abu-Rustum","year":"2006","unstructured":"Abu-Rustum NR, Alektiar K, Iasonos A et al (2006) The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 103:714\u2013718. https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.055","journal-title":"Gynecol Oncol"},{"key":"1838_CR44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ygyno.2017.06.004","volume":"146","author":"SC Hayes","year":"2017","unstructured":"Hayes SC, Janda M, Ward LC et al (2017) Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol 146:623\u2013629. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.004","journal-title":"Gynecol Oncol"},{"key":"1838_CR45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/igc.0000000000000405","volume":"25","author":"H Hareyama","year":"2015","unstructured":"Hareyama H, Hada K, Goto K et al (2015) Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study. Int J Gynecol Cancer 25:751\u2013757. https:\/\/doi.org\/10.1097\/igc.0000000000000405","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR46","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","volume":"8","author":"G Montagna","year":"2022","unstructured":"Montagna G, Zhang J, Sevilimedu V et al (2022) Risk factors and racial and ethnic disparities in patients with breast Cancer-related Lymphedema. JAMA Oncol 8:1195\u20131200. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1628","journal-title":"JAMA Oncol"},{"key":"1838_CR47","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamasurg.2014.23","volume":"149","author":"DM Black","year":"2014","unstructured":"Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD (2014) Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with Breast cancer. JAMA Surg 149:788\u2013796. https:\/\/doi.org\/10.1001\/jamasurg.2014.23","journal-title":"JAMA Surg"},{"key":"1838_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-016-3913-x","volume":"159","author":"ML Kwan","year":"2016","unstructured":"Kwan ML, Yao S, Lee VS et al (2016) Race\/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the pathways Study. Breast Cancer Res Treat 159:119\u2013129. https:\/\/doi.org\/10.1007\/s10549-016-3913-x","journal-title":"Breast Cancer Res Treat"},{"key":"1838_CR49","doi-asserted-by":"publisher","first-page":"154e","DOI":"10.1097\/prs.0000000000000268","volume":"134","author":"BJ Mehrara","year":"2014","unstructured":"Mehrara BJ, Greene AK (2014) Lymphedema and obesity: is there a link? Plast Reconstr Surg 134:154e\u201360e. https:\/\/doi.org\/10.1097\/prs.0000000000000268","journal-title":"Plast Reconstr Surg"},{"key":"1838_CR50","doi-asserted-by":"publisher","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GKD, Scott-Conner C (2018) Lymphedema following Breast cancer: the importance of surgical methods and obesity. Front Womens Health.\u00a0https:\/\/doi.org\/10.15761\/fwh.1000144","DOI":"10.15761\/fwh.1000144"},{"key":"1838_CR51","doi-asserted-by":"publisher","first-page":"8241710","DOI":"10.1155\/2016\/8241710","volume":"2016","author":"LT Dean","year":"2016","unstructured":"Dean LT, Kumar A, Kim T et al (2016) Race or Resource? BMI, race, and other social factors as risk factors for interlimb differences among overweight breast cancer survivors with lymphedema. J Obes. 2016:8241710. https:\/\/doi.org\/10.1155\/2016\/8241710","journal-title":"J Obes."},{"key":"1838_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/phm.0000000000000178","volume":"94","author":"JC Brown","year":"2015","unstructured":"Brown JC, Kumar A, Cheville AL et al (2015) Association between Lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. Am J Phys Med Rehabil 94:288\u2013296. https:\/\/doi.org\/10.1097\/phm.0000000000000178","journal-title":"Am J Phys Med Rehabil"},{"key":"1838_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00520-013-1962-9","volume":"22","author":"JC Brown","year":"2014","unstructured":"Brown JC, Cheville AL, Tchou JC, Harris SR, Schmitz KH (2014) Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer 22:135\u2013143. https:\/\/doi.org\/10.1007\/s00520-013-1962-9","journal-title":"Support Care Cancer"},{"key":"1838_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1524-4741.2000.99072.x","volume":"6","author":"ED Paskett","year":"2000","unstructured":"Paskett ED, Stark N (2000) Lymphedema: knowledge, treatment, and impact among Breast Cancer survivors. Breast J 6:373\u2013378. https:\/\/doi.org\/10.1046\/j.1524-4741.2000.99072.x","journal-title":"Breast J"},{"key":"1838_CR55","doi-asserted-by":"publisher","first-page":"e0182791","DOI":"10.1371\/journal.pone.0182791","volume":"12","author":"JN Hellwege","year":"2017","unstructured":"Hellwege JN, Torstenson ES, Russell SB, Edwards TL, Velez Edwards DR (2017) Evidence of selection as a cause for racial disparities in fibroproliferative Disease. PLoS ONE 12:e0182791. https:\/\/doi.org\/10.1371\/journal.pone.0182791","journal-title":"PLoS ONE"},{"key":"1838_CR56","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1111\/jdv.16097","volume":"34","author":"A Diaz","year":"2020","unstructured":"Diaz A, Tan K, He H et al (2020) Keloid lesions show increased IL-4\/IL-13 signaling and respond to Th2-targeting dupilumab therapy. J Eur Acad Dermatol Venereol 34:e161\u2013e4. https:\/\/doi.org\/10.1111\/jdv.16097","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1838_CR57","first-page":"141","volume":"10","author":"G Godin","year":"1985","unstructured":"Godin G, Shephard RJ (1985) A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 10:141\u2013146","journal-title":"Can J Appl Sport Sci"},{"key":"1838_CR58","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11764-015-0430-6","volume":"9","author":"S Amireault","year":"2015","unstructured":"Amireault S, Godin G, Lacombe J, Sabiston CM (2015) Validation of the Godin-Shephard leisure-time physical activity questionnaire classification coding system using accelerometer assessment among Breast cancer survivors. J Cancer Surviv 9:532\u2013540. https:\/\/doi.org\/10.1007\/s11764-015-0430-6","journal-title":"J Cancer Surviv"},{"key":"1838_CR59","first-page":"18","volume":"4","author":"G Godin","year":"2011","unstructured":"Godin G (2011) The Godin-Shephard leisure-time physical activity questionnaire. The Health & Fitness Journal of Canada 4:18\u201322","journal-title":"The Health & Fitness Journal of Canada"},{"key":"1838_CR60","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ygyno.2019.09.027","volume":"155","author":"J Carter","year":"2019","unstructured":"Carter J, Huang HQ, Armer J et al (2019) GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). Gynecol Oncol. 155:452\u2013460. https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.027","journal-title":"Gynecol Oncol."},{"key":"1838_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/SLA.0b013e31817ed7c3","volume":"248","author":"AJ Spillane","year":"2008","unstructured":"Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF (2008) Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with Melanoma using classification and regression tree analysis. Ann Surg 248:286\u2013293. https:\/\/doi.org\/10.1097\/SLA.0b013e31817ed7c3","journal-title":"Ann Surg"},{"key":"1838_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ygyno.2019.02.021","volume":"153","author":"CH Watson","year":"2019","unstructured":"Watson CH, Lopez-Acevedo M, Broadwater G et al (2019) A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging Surgery. Gynecol Oncol 153:399\u2013404. https:\/\/doi.org\/10.1016\/j.ygyno.2019.02.021","journal-title":"Gynecol Oncol"},{"key":"1838_CR63","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ygyno.2020.10.026","volume":"160","author":"S Russo","year":"2021","unstructured":"Russo S, Walker JL, Carlson JW et al (2021) Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol 160:625\u2013632. https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.026","journal-title":"Gynecol Oncol"},{"key":"1838_CR64","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ygyno.2010.01.022","volume":"117","author":"J Carter","year":"2010","unstructured":"Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR (2010) A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol 117:317\u2013323. https:\/\/doi.org\/10.1016\/j.ygyno.2010.01.022","journal-title":"Gynecol Oncol"},{"key":"1838_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ygyno.2023.05.070","volume":"175","author":"PK Bjerre Trent","year":"2023","unstructured":"Bjerre Trent PK, Nordskar NJ, Wangen KR et al (2023) Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: a population based cross-sectional study. Gynecol Oncol 175:72\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.070","journal-title":"Gynecol Oncol"},{"key":"1838_CR66","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.apjon.2022.100153","volume":"10","author":"YY Hsu","year":"2023","unstructured":"Hsu YY, Liu CY, Ho CL, Hsu KF (2023) Determinants of quality of life related to lower limb lymphedema in women with gynecological cancer Surgery. Asia Pac J Oncol Nurs 10:100153. https:\/\/doi.org\/10.1016\/j.apjon.2022.100153","journal-title":"Asia Pac J Oncol Nurs"},{"key":"1838_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","volume":"103","author":"SGR McDuff","year":"2019","unstructured":"McDuff SGR, Mina AI, Brunelle CL et al (2019) Timing of Lymphedema after treatment for Breast Cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys 103:62\u201370. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1838_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0038-1635117","volume":"32","author":"AK Greene","year":"2018","unstructured":"Greene AK, Goss JA (2018) Diagnosis and staging of Lymphedema. Semin Plast Surg 32:12\u201316. https:\/\/doi.org\/10.1055\/s-0038-1635117","journal-title":"Semin Plast Surg"},{"key":"1838_CR69","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0268355520938283","volume":"35","author":"AP Gasparis","year":"2020","unstructured":"Gasparis AP, Kim PS, Dean SM, Khilnani NM, Labropoulos N (2020) Diagnostic approach to lower limb edema. Phlebology 35:650\u2013655. https:\/\/doi.org\/10.1177\/0268355520938283","journal-title":"Phlebology"},{"key":"1838_CR70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"key":"1838_CR71","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2519\/jospt.1999.29.10.609","volume":"29","author":"EJ Petersen","year":"1999","unstructured":"Petersen EJ, Irish SM, Lyons CL et al (1999) Reliability of water volumetry and the figure of eight method on subjects with ankle joint swelling. J Orthop Sports Phys Ther 29:609\u2013615. https:\/\/doi.org\/10.2519\/jospt.1999.29.10.609","journal-title":"J Orthop Sports Phys Ther"},{"key":"1838_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gore.2015.12.002","volume":"15","author":"EE Hopp","year":"2016","unstructured":"Hopp EE, Osborne JL, Schneider DK, Bojar CJ, Uyar DS (2016) A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer. Gynecol Oncol Rep 15:25\u201328. https:\/\/doi.org\/10.1016\/j.gore.2015.12.002","journal-title":"Gynecol Oncol Rep"},{"key":"1838_CR73","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejogrb.2017.02.021","volume":"211","author":"E Lindqvist","year":"2017","unstructured":"Lindqvist E, Wedin M, Fredrikson M, Kj\u00f8lhede P (2017) Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 211:112\u2013121. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.02.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1838_CR74","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/lrb.2021.0035","volume":"20","author":"H Zhang","year":"2022","unstructured":"Zhang H, Kong W, Han C, Liu T, Li J, Song D (2022) Current status and progress in the Treatment of Lower Limb Lymphedema after Treatment of Gynecological Oncology. Lymphatic Res Biology 20:308\u2013314. https:\/\/doi.org\/10.1089\/lrb.2021.0035","journal-title":"Lymphatic Res Biology"},{"key":"1838_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5306\/wjco.v5.i3.241","volume":"5","author":"MR Fu","year":"2014","unstructured":"Fu MR (2014) Breast cancer-related lymphedema: symptoms, diagnosis, risk reduction, and management. World J Clin Oncol 5:241\u2013247. https:\/\/doi.org\/10.5306\/wjco.v5.i3.241","journal-title":"World J Clin Oncol"},{"key":"1838_CR76","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG (2018) Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 7:379\u2013403. https:\/\/doi.org\/10.21037\/gs.2017.11.04","journal-title":"Gland Surg"},{"key":"1838_CR77","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/1097-0142(195311)6:6<1238::AID-CNCR2820060618>3.0.CO;2-6","volume":"6","author":"AI Sherman","year":"1953","unstructured":"Sherman AI, Ter-Pogossian M (1953) Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer 6:1238\u20131240.","journal-title":"Cancer"},{"key":"1838_CR78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/radiation3010004","volume":"3","author":"L Mango","year":"2023","unstructured":"Mango L (2023) Lymphoscintigraphic Indications in the diagnosis, Management and Prevention of Secondary Lymphedema. Radiation 3:40\u201345","journal-title":"Radiation"},{"key":"1838_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4274\/mirt.58077","volume":"24","author":"S Kara\u00e7avu\u015f","year":"2015","unstructured":"Kara\u00e7avu\u015f S, Y\u0131lmaz YK, Ekim H (2015) Clinical significance of Lymphoscintigraphy findings in the evaluation of Lower Extremity Lymphedema. Mol Imaging Radionucl Ther 24:80\u201384. https:\/\/doi.org\/10.4274\/mirt.58077","journal-title":"Mol Imaging Radionucl Ther"},{"key":"1838_CR80","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10147-014-0724-0","volume":"20","author":"I Deura","year":"2015","unstructured":"Deura I, Shimada M, Hirashita K et al (2015) Incidence and risk factors for lower limb lymphedema after gynecologic cancer Surgery with initiation of periodic complex decongestive physiotherapy. Int J Clin Oncol 20:556\u2013560. https:\/\/doi.org\/10.1007\/s10147-014-0724-0","journal-title":"Int J Clin Oncol"},{"key":"1838_CR81","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/lrb.2017.0039","volume":"16","author":"AR Sharkey","year":"2018","unstructured":"Sharkey AR, King SW, Kuo RY, Bickerton SB, Ramsden AJ, Furniss D (2018) Measuring limb volume: Accuracy and Reliability of Tape Measurement Versus Perometer Measurement. Lymphat Res Biol 16:182\u2013186. https:\/\/doi.org\/10.1089\/lrb.2017.0039","journal-title":"Lymphat Res Biol"},{"key":"1838_CR82","doi-asserted-by":"publisher","unstructured":"Mirandola D, Muraca MG, Sgambati E, Manetti M, Marini M (2019) Role of a structured physical activity pathway in improving functional disability, Pain and Quality of Life in a case of breast and Gynecological Cancer Survivorship. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8040531","DOI":"10.3390\/jcm8040531"},{"key":"1838_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101471","author":"WI Chang","year":"2019","unstructured":"Chang WI, Kang HC, Wu HG et al (2019) Lower extremity lymphedema in gynecologic cancer patients: Propensity score matching analysis of external beam radiation versus brachytherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11101471","journal-title":"Cancers (Basel)"},{"key":"1838_CR84","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ygyno.2020.10.023","volume":"160","author":"J Carter","year":"2021","unstructured":"Carter J, Huang HQ, Armer J et al (2021) GOG 244 - the Lymphedema and gynecologic cancer (LeG) study: the impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol 160:244\u2013251. https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.023","journal-title":"Gynecol Oncol"},{"key":"1838_CR85","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/s1470-2045(17)30068-2","volume":"18","author":"EC Rossi","year":"2017","unstructured":"Rossi EC, Kowalski LD, Scalici J et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18:384\u2013392. https:\/\/doi.org\/10.1016\/s1470-2045(17)30068-2","journal-title":"Lancet Oncol"},{"key":"1838_CR86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ijgc-2020-001924","volume":"31","author":"G Glaser","year":"2021","unstructured":"Glaser G, Dinoi G, Multinu F et al (2021) Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer. Int J Gynecol Cancer 31:85\u201391. https:\/\/doi.org\/10.1136\/ijgc-2020-001924","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR87","unstructured":"National Library of Medicine. Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer. [Internet]. Accessed August 15 (2023) Accessed at: https:\/\/clinicaltrials.gov\/study\/NCT05646316"},{"key":"1838_CR88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2407-9-47","volume":"9","author":"H Tada","year":"2009","unstructured":"Tada H, Teramukai S, Fukushima M, Sasaki H (2009) Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer 9:47. https:\/\/doi.org\/10.1186\/1471-2407-9-47","journal-title":"BMC Cancer"},{"key":"1838_CR89","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/igc.0000000000000341","volume":"25","author":"N Biglia","year":"2015","unstructured":"Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A (2015) Lower limb lymphedema and neurological Complications after lymphadenectomy for gynecological cancer. Int J Gynecol Cancer 25:521\u2013525. https:\/\/doi.org\/10.1097\/igc.0000000000000341","journal-title":"Int J Gynecol Cancer"},{"key":"1838_CR90","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.suronc.2016.05.015","volume":"25","author":"AA Mendivil","year":"2016","unstructured":"Mendivil AA, Rettenmaier MA, Abaid LN et al (2016) Lower-extremity lymphedema following management for endometrial and Cervical cancer. Surg Oncol 25:200\u2013204. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.015","journal-title":"Surg Oncol"},{"key":"1838_CR91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/COC.0b013e318277d5f4","volume":"37","author":"Z Nicholas","year":"2014","unstructured":"Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2014) Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol 37:131\u2013134. https:\/\/doi.org\/10.1097\/COC.0b013e318277d5f4","journal-title":"Am J Clin Oncol"},{"key":"1838_CR92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2014.11.006","volume":"136","author":"VL Beesley","year":"2015","unstructured":"Beesley VL, Rowlands IJ, Hayes SC et al (2015) Incidence, risk factors and estimates of a woman\u2019s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol 136:87\u201393. https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.006","journal-title":"Gynecol Oncol"},{"key":"1838_CR93","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ygyno.2012.06.007","volume":"127","author":"LV an de Poll-Franse","year":"2012","unstructured":"an de Poll-Franse LV, Pijnenborg JM, Boll D et al (2012) Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study. Gynecol Oncol 127:153\u2013160. https:\/\/doi.org\/10.1016\/j.ygyno.2012.06.007","journal-title":"Gynecol Oncol"},{"key":"1838_CR94","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.21873\/anticanres.11785","volume":"37","author":"N Biglia","year":"2017","unstructured":"Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE (2017) Lower body lymphedema in patients with Gynecologic Cancer. Anticancer Res 37:4005\u20134015. https:\/\/doi.org\/10.21873\/anticanres.11785","journal-title":"Anticancer Res"},{"key":"1838_CR95","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10147-019-01608-6","volume":"25","author":"T Kunitake","year":"2020","unstructured":"Kunitake T, Kakuma T, Ushijima K (2020) Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment. Int J Clin Oncol 25:963\u2013971. https:\/\/doi.org\/10.1007\/s10147-019-01608-6","journal-title":"Int J Clin Oncol"},{"key":"1838_CR96","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1249\/mss.0000000000000360","volume":"46","author":"SM Hammer","year":"2014","unstructured":"Hammer SM, Brown JC, Segal S, Chu CS, Schmitz KH (2014) Cancer-related impairments influence physical activity in Uterine cancer survivors. Med Sci Sports Exerc 46:2195\u20132201. https:\/\/doi.org\/10.1249\/mss.0000000000000360","journal-title":"Med Sci Sports Exerc"},{"key":"1838_CR97","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1249\/MSS.0b013e318299afd4","volume":"45","author":"JC Brown","year":"2013","unstructured":"Brown JC, John GM, Segal S, Chu CS, Schmitz KH (2013) Physical activity and lower limb lymphedema among Uterine cancer survivors. Med Sci Sports Exerc 45:2091\u20132097. https:\/\/doi.org\/10.1249\/MSS.0b013e318299afd4","journal-title":"Med Sci Sports Exerc"},{"key":"1838_CR98","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2522\/ptj.20120088","volume":"93","author":"KJ Yost","year":"2013","unstructured":"Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC (2013) Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther 93:694\u2013703. https:\/\/doi.org\/10.2522\/ptj.20120088","journal-title":"Phys Ther"},{"key":"1838_CR99","doi-asserted-by":"publisher","first-page":"829","DOI":"10.31083\/j.ceog.2020.06.5531","volume":"47","author":"SH Ryu","year":"2020","unstructured":"Ryu SH, Jang BS, Lee JH, Jeong HJ, Kim GC, Sim YJ (2020) Comparison of bilateral lymphedema and unilateral lymphedema in lower extremities after gynecologic cancer Surgery. CEOG 47:829\u2013834. https:\/\/doi.org\/10.31083\/j.ceog.2020.06.5531","journal-title":"CEOG"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01838-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01838-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01838-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T09:24:24Z","timestamp":1714037064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01838-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01838-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no potential or actual competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This analysis was approved by the University of North Carolina at Chapel Hill (UNC-CH IRB# 23<b>\u2013<\/b>0666).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to participate"}},{"value":"All data is deidentified, therefore, consent to publish was not obtained from participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to Publish"}}]}}